Skip to main content
  • Review
  • Published:

Enterobacter sakazakii: an emerging foodborne pathogenic bacterium

Abstract

Enterobacter sakazakii (Cronobacter spp.) is an emerging pathogen associated with the ingestion of contaminated powdered infant formula (PIF) that causes necrotizing enterocolitis, sepsis, and meningitis in low-birth-weight preterm neonatal infants. The natural habitat of E. sakazakii is unknown, but PIF has been suggested as a possible mode of transmission in neonatal infections. The presence of E. sakazakii is not limited to powdered infant formula, it can also be found in a broad range of foods and in water. In recent years, the International Commission on Microbiological Specifications for Foods has ranked E. sakazakii a “severe hazard for restricted populations.” The present review is mainly focused on environmental stress on E. sakazakii and its antibiotic resistance.

Introduction

Enterobacter sakazakii, a Gram-negative, rod-shaped bacterium, is a rare cause of invasive infection with high death rates in neonates. The organism was formerly referred to as “yellow-pigmented” Enterobacter cloacae, and was characterized as a unique species 30 years ago (Farmer et al. 1980). Initially, it was noted to be an opportunistic pathogen responsible for neonatal sepsis and meningitis (Simmons et al. 1989; Biering et al. 1989; Clark et al. 1990). The infections have been linked to ingestion of powdered infant formula (PIF) that has not been thermally sterilized (Hunter et al. 2008). In a recent study on the occurrence of E. sakazakii in production environments from food (milk powder, chocolate, cereal, potato, and pasta) factories and households, this organism was isolated with varying frequency from nearly all environments examined, strongly indicating that it is widespread (Lehner and Stephan 2004). It was reported that the E. sakazakii was able to adhere to and grow on latex, polycarbonate, silicon and to a lesser extent stainless steel (Iversen et al. 2004). Schindler and Metz (1991) found E. sakazakii with overall frequencies of 1.8% (10/564 strains) and 0.4% (1/256 strains) investigating central and local drinking water supplies.

Recently, most of the attention paid to E. sakazakii-related contamination of food products has focused on PIF. In 2002, the U.S. Food and Drug Administration (FDA) published a warning regarding the presence of E. sakazakii in baby formula (U.S.FDA. 2002). PIF is not manufactured as a sterile preparation, and some heat-resistant E. sakazakii isolates expressed a higher level of infB than did the heat-sensitive isolates. The infB gene encodes the prokaryotic translation initiation factor (IF2), which plays a very important functional role in stress-response mechanisms of this pathogen (Asakura et al. 2007). Moreover, producing capsular materials may provide protection for the organism, facilitating its survival in a desiccated environment (Drudy et al. 2006). Enterobacter sakazakii can adhere to plastics and silicon rubber surfaces and grow in a biofilm; biofilm formation may also be a factor associated with altered susceptibility to antimicrobials (Iversen et al. 2004; Lehner et al. 2005). Enterobacter sakazakii may exhibit long-term persistence in dried infant formula and has been reported to be the only organism isolated after a 2.5-year period of storage (Riedel and Lehner 2007).

This paper is aimed at giving an overview on E. sakazakii, a very important foodborne pathogenic bacterium that causes serious infections among infants, especially the preterm neonates.

Reservoirs of Enterobacter sakazakii

The natural reservoir of E. sakazakii has not yet been characterized, but the organism can be found in a variety of environments and food (FAO 2004; Iversen and Forsythe 2004). Kandhai et al. (2004) isolated E. sakazakii from milk powder manufacturing facilities and household vacuum cleaners, thus confirming its ubiquitous distribution. Enterobacter sakazakii has also been isolated from milk powders, baby foods, beef, sausage meat, cheese products, and vegetables (Leclercq et al. 2002, Muytjens and Kollee 1990). Nevertheless, E. sakazakii was not detected in other environmental settings, including surface water, soil, mud, rotting wood, grain, bird droppings, domestic animals, cattle, or cows’ milk (Muytjens and Kollee 1990). In addition, E. sakazakii has been isolated from a wide range of clinical sources, including cerebrospinal fluid (CSF), blood, bone marrow, sputum, urine, inflamed appendix tissue, intestinal and respiratory tracts, and wounds (Gurtler and Beuchat 2005; Ray et al. 2007; Bhat et al. 2009). In addition, the hospital environment provides a befitting survival space for E. sakazakii.

Infections associated with Enterobacter sakazakii

Feeding with E. sakazakii-contaminated PIF has been epidemiologically implicated in several clinical cases. The first cases of neonatal meningitis probably caused by E. sakazakii were reported in 1961 (Urmenyi and Franklin 1961). Since then, a lot of infection cases associated with this organism have been reported in many countries (Table 1). Although most cases have been reported in developed countries, few E. sakazakii infections described in India have been reported (Ray et al. 2007; Bhat et al. 2009).

Table 1 Cases of E. sakazakii infection in neonates and infants (1961–2009)

Bowen and Braden (2006) analyzed 46 cases of invasive infant E. sakazakii infection. Twelve infants had bacteremia, 33 had meningitis, and 1 had a urinary tract infection. The PIF samples associated with 15 (32.6%) of 46 cases yielded E. sakazakii; in 13 cases, clinical and formula strains were indistinguishable. E. sakazakii was obtained from the vaginal smear (PH 5.5) of a 26-year-old woman in Budapest. Importantly, she had bathed in the resort lake Balaton with water temperature 26–28°C (Ongrádi 2002).

The mortality rate of infections caused by E. sakazakii ranged from 40 to 80% (Nazarowec-White and Farber 1997; Sethi and Prakash 2010). Clearly, the severity of the infection in infants as well as the scarcity of information on the ecology and pathogenicity of this organism warrant further studies on clinical and microbiological features of this foodborne pathogen.

Environmental stress on Enterobacter sakazakii

Thermal treatment of foods prior to consumption has long been used as a primary means of reducing the risks associated with foodborne pathogens. Enterobacter sakazakii has been reported thermotolerant. Kim and Park (2007) studied thermal resistance and inactivation of E. sakazakii isolates during rehydration of PIF and found that the thermal resistance of E. sakazakii increased in rehydrated PIF compared with in saline. Moreover, the ability of E. sakazakii to form biofilms and survive desiccation conditions may contribute to its survival in infant formula factory environments and subsequent desiccated products (Iversen et al. 2004; Grimm et al. 2008). Beuchat et al. (2009) studied factors affecting the survival, growth, and inactivation of E. sakazakii, and their studies clearly indicated that its survival was influenced by α w and temperature, and that survival was favored by low α w and low storage temperature. Shaker et al. (2008) have already shown that desiccation and heat stresses caused significant reduction in D-values of E. sakazakii strains as used in the present study.

Nazarowec-White and Farber (1997) found that E. sakazakii strains was highly heat-tolerant and showed a wide range of growing temperatures. Shaker et al. (2008) studied thermal inactivation of stressed E. sakazakii in PIF with hot water at various temperatures, when the temperature of water was increased to 70°C, a significant reduction in stressed cells compared with the unstressed cells by approximately 1 log10. But there were no significant differences when PIF was reconstituted with water at 80, 90, and 100°C where the populations were <1 log10. So, to reduce the risk of E. sakazakii contamination from PIF, it is recommended that the water at the appropriate temperature for rehydration.

Environmental stresses such as acid and cold have been reported. Johler et al. (2010) found E. sakazakii isolates survived under conditions of low pH and were able to grow to approximately 109 CFU/ml within 24 h at pH 4.5. This is of particular interest in terms of the survival of E. sakazakii in the stomach after ingestion, since neonates tend to show higher gastric pH levels than adults (Maffei and Nobrega 1975). Iversen et al. (2004) reported that E. sakazakii were able to grow in PIF during storage at refrigeration temperatures and attach to infant-feeding equipment, which may become reservoirs of infection. Therefore, trying to reduce the storage time of PIF is obviously essential.

Antibiotic resistance

Although E. sakazakii has been detected in multiple food sources, a strong association has been found only with PIF. Its antibiotic susceptibility has also been conducted after some fatal infections among infants reported (Van Acker et al. 2001; Simmons et al. 1989; Arseni et al. 1987). Oonaka et al. (2010) found E. sakazakii isolates from PIF were resistant to ampicillin and lincomycin, while sensitive to gentamicin and cephalosporins. Shadlia-Matug et al. (2008) reported that E. sakazakii isolates were resistant to penicillin G, ampicillin and cephalothin, and also sensitive to gentamicin. Enterobacter sakazakii infections have been traditionally treated with ampicillin-gentamicin or ampicillin-chloramphenicol (Lai 2001). However, resistance to ampicillin has emerged due to the acquisition of transposable elements and the production of β-lactamases (Pitout et al. 1997; Girlich et al. 2001). Consequently, consideration should be given to the use of carbapenems or the newer cephalosporins in combination with a second agent, such as an aminoglycoside. The use of trimethoprim-sulfamethoxazole may also be useful (Lai 2001). It is recommended that the antibiotic-resistance pattern of the organism be established early on, so the infection can be treated properly from the beginning.

In conclusion, surveillance of emerging resistance of E. sakazakii is of paramount importance. And collection of updated data is mandatory for appropriate use of antibiotics. To select antibiotics conscientiously according to susceptibility tests is very important.

Prevention strategies

Enterobacter sakazakii is recognized as a foodborne pathogen associated with the contaminated PIF. In order to reduce the risk associated to consumption of contaminated formulas, correct information and education regarding good practices required during preparation and handling of this product are required.

A variety of strategies have been suggested to minimize the risk of E. sakazakii contamination of infant formula, including the use of gamma radiation and E. sakazakii-targeted bacteriophage therapy to reduce bacterial growth (Lee et al. 2006; Kim et al. 2007). Furthermore, in considering the thermal characteristics of E. sakazakii, Kim and Park (2007) recommended that rehydration of powdered infant formula for infant feeding with water at more than 60°C may be more helpful for the reduction of E. sakazakii with minimal nutrient reduction. For the high risk population (preterm neonates, infected infants), a sterilized rehydrated PIF to feed them is demanded. And physicians and other caregivers must advocate breast-feeding as the preferred means of feeding infants.

Conclusion

Enterobacter sakazakii is an emerging foodborne pathogen, often transmitted through PIF and responsible for a series of infections, some of which with potential fatal outcomes in a particular segment of the population. So, preventive measures by parents, infant formula manufacturers, and health care providers will be important in the prevention of E. sakazakii-related infections. We recommend more preventative strategies be applied in the process of PIF products to avoid being contaminated by this foodborne pathogen.

Given increasing reports of antibiotic resistance, we hope there will be antibiotic susceptibility test before using antibiotics. And better understanding of the pathogenesis E. sakazakii-related diseases will help in the development of new modes of prevention for this emerging pathogen.

References

  • Adamson DM, Rogers JR (1981) Enterobacter sakazakii meningitis with sepsis. Clin Microbiol Newsl 3:19–20

    Article  Google Scholar 

  • Arseni A, Malamou-Ladas E, Koutsia C, Xanthou M, Trikka E (1987) Outbreak of colonization of neonates with Enterobacter sakazakii. J Hosp Infect 9:143–150

    Article  PubMed  CAS  Google Scholar 

  • Asakura H, Morita-Ishihara T, Yamamoto S, Igimi S (2007) Genetic characterization of thermal tolerance in Enterobacter sakazakii. Microbiol Immunol 51:671–677

    PubMed  CAS  Google Scholar 

  • Bar-Oz B, Preminger A, Peleg O, Block C, Arad I (2001) Enterobacter sakazakii infections in the newborn. Acta Paediatr 90:356–358

    Article  PubMed  CAS  Google Scholar 

  • Beuchat LR, Kim H, Gurtler JB, Lin LC, Ryu JH, Richards GM (2009) Cronobacter sakazakii in foods and factors affecting its survival, growth, and inactivation. Int J Food Microbiol 136:204–213

    Article  PubMed  CAS  Google Scholar 

  • Bhat GK, Anandhi RS, Dhanya VC, Shenoy SM (2009) Urinary tract infection due to Enterobacter sakazakii. Indian J Pathol Microbiol 52:430–431

    Article  PubMed  Google Scholar 

  • Biering G, Karlsson S, Clark NC, Jónsdóttir KE, Lúdvígsson P, Steingrímsson O (1989) Three cases of neonatal meningitis caused by Enterobacter sakazakii in powdered milk. J Clin Microbiol 27:2054–2056

    PubMed  CAS  Google Scholar 

  • Block C, Peleg O, Minster N, Bar-Oz B, Simhon A, Arad I, Shapiro M (2002) Cluster of neonatal infections in Jerusalem due to unusual biochemical variant of Enterobacter sakazakii. Eur J Clin Microbiol Infect Dis 21:613–616

    Article  PubMed  CAS  Google Scholar 

  • Bowen A, Braden CR (2006) Invasive Enterobacter sakazakii disease in infants. Emerg Infect Dis 12:1185–1189

    Article  PubMed  Google Scholar 

  • Burdette JH, Santos C (2000) Enterobacter sakazakii brain abscess in the neotate: The importance of neuroradiologic imaging. Pediatr Radiol 30:33–34

    Article  PubMed  CAS  Google Scholar 

  • Chan KL, Saing H, Yung RW, Yeung YP, Tsoi NS (1994) A study of preantibiotic bacteriology in 125 patients with necrotizing enterocolitis. Acta Paediatr Suppl 396:45–48

    Article  PubMed  CAS  Google Scholar 

  • Clark NC, Hill BC, O’Hara CM, Steingrimsson O, Cooksey RC (1990) Epidemiologic typing of Enterobacter sakazakii in two neonatal nosocomial outbreaks. Diagn Microbiol Infect Dis 13:467–472

    Article  PubMed  CAS  Google Scholar 

  • Coignard B, Vaillant V, Vincent JP, Lefleche A, Mariani-Kurkdjian P et al. (2004) Infections severs a Enterobacter sakazakii chez des nouveau-nes ayant consomme une prepartation en poudre pour nourrissons, France. Bull Epidemiol Hebdomadaire. http://www.invs.sante.fr/BEh/2006/02_03/beh_02_03_2006.pdf. Accessed 26 December 2010

  • Drudy D, Mullane NR, Quinn T, Wall PG, Fanning S (2006) Enterobacter sakazakii: An emerging pathogen in powdered infant formula. Clin Infect Dis 42:996–1002

    Article  PubMed  CAS  Google Scholar 

  • Farmer JJ, Aabury MA, Hickman FW, Brenner DJ (1980) Enterobacter sakazakii: a new species of “Enterobacteriaceae” isolated from clinical specimens. Int J Syst Bacteriol 30:569–584

    Article  Google Scholar 

  • Food and Agriculture Organisation (2004) Final report of the FAO/WHO Regional Conference on Food Safety for Asia and the Pacific Annex 6 FAO http://www.fao.org/docrep/meeting/008/ad911e/ad911e06. Accessed 25 December 2010

  • Gallagher PG, Ball WS (1991) Cerebral infarctions due to CNS infection with Enterobacter sakazakii. Pediatr Radiol 21:135–136

    Article  PubMed  CAS  Google Scholar 

  • Girlich D, Poirel L, Leelaporn A, Karim A, Tribuddharat C, Fennewald M, Nordmann P (2001) Molecular epidemiology of the integron-located VEB-1 extended-spectrum beta-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand. J Clin Microbiol 39:175–182

    Article  PubMed  CAS  Google Scholar 

  • Grimm M, Stephan R, Iversen C, Manzardo GGG, Rattei T, Riedel K, Ruepp A, Frishman D, Lehner A (2008) Cellulose and extracellular matrix component present in Enterobacter sakazakii biofilms. J Food Prot 71:13–18

    PubMed  CAS  Google Scholar 

  • Gurtler JB, Beuchat LR (2005) Performance of media for recovering stressed cells of Enterobacter sakazakii as determined using spiral plating and ecometric techniques. Appl Environ Microbiol 71:7661–7669

    Article  PubMed  CAS  Google Scholar 

  • Himelright I, Harris E, Lorch V, Anderson M, Jones T, Craig A, Kuehnert M, Fotster T, Arduino M, Jensen B, Jernigan D (2002) Enterobacter sakazakii infections associated with the use of powdered infant formula-Tenessee, 2001. Morbid Mort Weekly Rep 51:297–300

    Google Scholar 

  • Hunter CJ, Petrosyan M, Ford HR, Prasadarao NV (2008) Enterobacter sakazakii: An emerging pathogen in infants and neonates. Surg Infect (Larchmt) 9:533–539

    Article  Google Scholar 

  • Iversen C, Forsythe S (2004) Isolation of Enterobacter sakazakii and other Enterobacteriaceae from powdered infant formula and related products. Food Microbiol 21:771–776

    Article  CAS  Google Scholar 

  • Iversen C, Lane M, Forsythe SJ (2004) The growth profile, thermotolerance and biofilm formation of Enterobacter sakazakii grow in infant formula milk. Lett Appl Microbiol 38:378–382

    Article  PubMed  CAS  Google Scholar 

  • Johler S, Stephan R, Hartmann I, Kuehner KA, Lehner A (2010) Genes involved in yellow pigmentation of Cronobacter sakazakii ES5 and influence of pigmentation on persistence and growth under environmental stress. Appl Environ Microbiol 76:1053–1061

    Article  PubMed  CAS  Google Scholar 

  • Joker RN, Norholm T, Siboni KF (1965) A case of neonatal meningitis caused by a yellow Enterobacter. Dan Med Bull 12:128–130

    PubMed  CAS  Google Scholar 

  • Kandhai MC, Reij MW, Gorris LG, Guillaume-Gentil O, van Schothorst M (2004) Occurrence of Enterobacter sakazakii in food production environments and households. Lancet 363:39–40

    Article  PubMed  Google Scholar 

  • Kim SH, Park JH (2007) Thermal resistance and inactivation of Enterobacter sakazakii isolates during rehydration of powdered infant formula. J Microbiol Biotechnol 17:364–368

    PubMed  Google Scholar 

  • Kim KP, Klumpp J, Loessner MJ (2007) Enterobacter sakazakii bacteriophages can prevent bacterial growth in reconstituted infant formula. Int J Food Microbiol 115:195–203

    Article  PubMed  CAS  Google Scholar 

  • Kleiman MB, Allen SD, Neal P, Reynolds J (1981) Meningoencephalitis and compartmentalization of the cerebral ventricles caused by Enterobacter sakazakii. J Clin Microbiol 14:352–354

    PubMed  CAS  Google Scholar 

  • Lai KK (2001) Enterobacter sakazakii infections among neonates, infants, children, and adults: case reports and a review of the literature. Medicine 80:113–122

    Article  PubMed  CAS  Google Scholar 

  • Leclercq A, Wanegue C, Baylac P (2002) Comparison of fecal coliform agar and violet red bile lactose agar for fecal coliform enumeration in foods. Appl Environ Microbiol 68:163–168

    Article  Google Scholar 

  • Lecour H, Seara A, Cordeiro J, Miranda M (1989) Treatment of childhood bacterial meningitis. Infection 17:343–346

    Article  PubMed  CAS  Google Scholar 

  • Lee JW, Oh SH, Kim JH, Yook HS, Byun MW (2006) Gamma radiation sensitivity of Enterobacter sakazakii in dehydrated powdered infant formula. J Food Prot 69:1434–1437

    PubMed  CAS  Google Scholar 

  • Lehner A, Stephan R (2004) Microbiological, epidemiological, and food safety aspects of Enterobacter sakazakii. J Food Prot 67:2850–2857

    PubMed  CAS  Google Scholar 

  • Lehner A, Riedel K, Eberel L, Breeuwer P, Diep B, Stephan R (2005) Biofilm formation, extracellular polysaccharide production, and cell-to-cell signaling in various Enterobacter sakazakii strains: aspects promoting environmental persistence. J Food Prot 68:2287–2294

    PubMed  CAS  Google Scholar 

  • Maffei HVL, Nobrega FJ (1975) Gastric pH and microflora of normal and diarrhoeic infants. Gut 16:719–726

    Article  PubMed  CAS  Google Scholar 

  • Monroe PW, Tift WL (1979) Bacteremia associated with Enterobacter sakazakii (yellow pigmented Enterobacter cloacae). J Clin Microbiol 10:850–851

    PubMed  CAS  Google Scholar 

  • Muytjens HL, Kollee LA (1990) Enterobacter sakazakii meningitis in neonates: causative role of formula? Pediatr Infect Dis J 9:372–373

    Article  PubMed  CAS  Google Scholar 

  • Muytjens HL, Zanen H, Sonderkamp H, Kollee L, Wachsmuth I, Farmer J (1983) Analysis of eight cases of neonatal meningitis and sepsis due to Enterobacter sakazakii. J Clin Microbiol 18:115–120

    PubMed  CAS  Google Scholar 

  • Naqvi SH, Maxwell MA, Dunkle LM (1985) Cefotaxime therapy of neonatal gram-negative bacillary meningitis. Pediatr Infect Dis 4:499–502

    Article  PubMed  CAS  Google Scholar 

  • Nazarowec-White M, Farber J (1997) Enterobacter sakazakii: a review. Int J Food Microbiol 34:103–113

    Article  PubMed  CAS  Google Scholar 

  • Noriega FR, Kotloff KL, Martin MA, Schwalbe RS (1990) Nosocomial bacteremia caused by Enterobacter sakazakii and Leuconostoc mesenteroides resulting from extrinsic contamination of infant formula. Pediatr Infect Dis J 9:447–448

    Article  PubMed  CAS  Google Scholar 

  • Ongrádi J (2002) Vaginal infection by Enterobacter sakazakii. Sex Transm Infect 78:467

    Article  PubMed  Google Scholar 

  • Oonaka K, Furuhata K, Hara M, Fukuyama M (2010) Powder infant formula milk contaminated with Enterobacter sakazakii. Jpn J Infect Dis 63:103–107

    PubMed  Google Scholar 

  • Pitout JD, Moland ES, Sanders CC, Thomson KS, Fitzsimmons SR (1997) Beta-lactamases and detection of beta-lactam resistance in Enterobacter spp. Antimicrob Agents Chemother 41:35–39

    PubMed  CAS  Google Scholar 

  • Postupa R, Aldova E (1984) Enterobacter sakazakii: A Tween 80 esterase-positive representative of the genus Enterobacter isolated from powdered milk specimens. J Hyg Epidemiol Microbiol Immunol 28:435–440

    PubMed  CAS  Google Scholar 

  • Ray P, Das A, Gautam V, Jain N, Narang A, Sharma M (2007) Enterobacter sakazakii infections: novel phenomenon in india. Indian J Med Microbiol 25:408–410

    Article  PubMed  CAS  Google Scholar 

  • Reina J, Parras F, Gil S, Salva F, Alomar P (1989) Human infections caused by Enterobacter sakazakii. Microbiologic considerations. Enferm Infecc Microbiol Clín 7:147–150

    PubMed  CAS  Google Scholar 

  • Reis M, Harms D, Scharf J (1994) Multiple cerebral infarcts with resulting multicystic encephalomalacia in a premature infant with Enterobacter sakazakii meningitis. Klin Pädiatr 206:184–186

    Article  Google Scholar 

  • Riedel K, Lehner A (2007) Identification of proteins involved in osmotic stress response in Enterobacter sakazakii by proteomics. Proteomics 7:1217–1231

    Article  PubMed  CAS  Google Scholar 

  • Schindler PRG, Metz H (1991) Coliform bacteria in drinking water from South Bavaria: Identification by the API 20E-system and resistance patterns. Water Sci Technol 24:81–84

    Google Scholar 

  • Sethi N, Prakash A (2010) In vitro susceptibility of Enterobacter sakazakii to natural products. J Food Technol 8:150–153

    Article  Google Scholar 

  • Shadlia-Matug M, Aidoo KE, Candlish AA, Elgerbi AM (2008) Evaluation of some antibiotics against pathogenic bacteria isolated from infant foods in North Africa. Open Food Sci J 2:95–101

    Article  CAS  Google Scholar 

  • Shaker RR, Osaili TM, Abu Al-Hassan AS, Ayyash MM, Forsythe SJ (2008) Effect of desiccation, starvation, heat and cold stresses on the thermal resistance of Enterobacter sakazakii in rehydrated infant milk formula. J Food Sci 73:354–359

    Article  Google Scholar 

  • Simmons BP, Gelfand MS, Haas M, Metts L, Ferguson J (1989) Enterobacter sakazakii infections in neonates associated with intrinsic contamination of a powdered infant formula. Infect Control Hosp Epidemiol 10:398–401

    Article  PubMed  CAS  Google Scholar 

  • Tekkok IH, Baeesa SS, Higgins MJ, Ventureyra EC (1996) Abscedation of posterior fossa dermoid cysts. Childs Nerv Syst 12:318–322

    Article  PubMed  CAS  Google Scholar 

  • U.S. Food and Drug Administration (2002) Isolation and enumeration of Enterobacter sakazakii from dehydrated infant formula. FDA. http://www.fda.gov/Food/ScienceResearch/LaboratoryMethods/ucm114665. Accessed 26 December 2010

  • Urmenyi AM, Franklin AW (1961) Neonatal death from pigmented coliform infection. Lancet 1:313–315

    Article  PubMed  CAS  Google Scholar 

  • Van Acker J, de Smet F, Muyldermans G, Bougatef A, Naessens A, Lauwers S (2001) Outbreak of necrotizing enterocolitis associated with Enterobacter sakazakii in powdered milk formula. J Clin Microbiol 39:293–297

    Article  PubMed  Google Scholar 

  • Willis J, Robinson JE (1988) Enterobacter sakazakii meningitis in neonates. Pediatr Infect Dis J 7:196–199

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to XianFeng Zhou.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhou, X., Fu, S., Gao, J. et al. Enterobacter sakazakii: an emerging foodborne pathogenic bacterium. Ann Microbiol 62, 1–5 (2012). https://doi.org/10.1007/s13213-011-0274-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13213-011-0274-x

Keywords